Health Care/Hospital

Poor home hygiene contributing to antibiotic resistance, warn global hygiene experts

LONDON, Sept. 11, 2020 /PRNewswire/ -- It is estimated that rates of resistance to commonly-used antibiotics could exceed 40–60% in some countries by 2030.1   With antimicrobial resistance (AMR) set to claim the lives of 10 million by 2050 if no action is taken,2 the GHC's experts are calling for ...

2020-09-11 07:01 3805

Gisele Buendchen Partners With Insight Timer To Encourage Millions To Meditate For Free

Gisele Buendchen And Insight Timer Respond To The Impact Of COVID-19 On Mental Health By Leading Free Guided Meditations And Live Events On Insight Timer In English And Portuguese. NEW YORK, Sept. 10, 2020 /PRNewswire/ -- Insight Timer, the world's largest free meditation app for anxiety, s...

2020-09-10 22:00 4439

Tottenham Acquisition I Limited Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Clene Nanomedicine, Inc.

NEW YORK, Sept. 10, 2020 /PRNewswire/ -- Tottenham Acquisition I Limited (Nasdaq: TOTA, TOTAU, TOTAW, TOTAR) ("Tottenham"), a publicly traded special purpose acquisition company, announced today that its subsidiary, Chelsea Worldwide Inc., has filed with the U.S. Securities and Exchange Commissio...

2020-09-10 20:56 21493

CMAB Biopharma and Laekna Therapeutics Enter Strategic Agreement for LAE005 Global Development and Commercialization Partnership

SUZHOU, China, Sept. 10, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), and Laekna Therapeutics Shanghai Co., Ltd. ("Laekna Therapeutics"), today announced a strategic collaboration agreement in Suzhou BioBAY for speedup of Immune Checkpoint Inhibitor (ICI) drug candidate to the clin...

2020-09-10 20:08 1938

Cernostics and Deciphex Announce Strategic Collaboration to Develop AI-Based Histology Diagnostics and Prognostics for Barrett's Esophagus

By combining Deciphex's unique digital pathology solutions with Cernostics tissue systems pathology approach, the partnership aims to generate novel predictive indicators using AI. PITTSBURGH and DUBLIN, Sept. 10, 2020 /PRNewswire/ -- Cernostics, a privately-held company focused on delivering ...

2020-09-10 20:00 2319

Merck Announces Positive Phase II Results for Investigational Sonelokinab (M1095) in Patients with Moderate to Severe Chronic Plaque-Type Psoriasis

Not intended for UK and US based media - Sonelokinab is an investigational IL-17 A/F Nanobody®, which neutralizes both IL-17A and IL-17F - Phase II study was facilitated by Avillion as part of an innovative co-development model DARMSTADT, Germany, Sept. 10, 2020 /PRNewswire/ -- Merck, a leadin...

2020-09-10 20:00 2716

Seneca Biopharma, Inc. Announces Completion of Phase II Clinical Study in China for the Treatment of Ischemic Stroke

GERMANTOWN, Maryland, Sept. 10, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the last subject completed their final follow-up assessment in the Company's...

2020-09-10 20:00 3271

Venus Medtech Taps into Surgical Heart Valve Market by Cooperating with Haoyue Group to Develop the Business of High-end Biomaterial Medical Devices

HANGZHOU, China, Sept. 10, 2020 /PRNewswire/ -- The leading transcatheter heart valve medical device player inChina - Venus Medtech (Hangzhou) Inc. ("Venus Medtech" or the "Company", together with its subsidiaries, the "Group", stock code: 2500) andJilin Changchun Haoyue Halal Meat Co., Ltd ("Hao...

2020-09-10 17:56 10022

Haoma Medica to Present Scientific Data on NaQuinate, a Potential New Treatment for Osteoporosis, at ASBMR 2020 Annual Meeting

LONDON, Sept. 10, 2020 /PRNewswire/ -- Haoma Medica announced today that it will present three scientific posters on NaQuinate at the American Society for Bone and Mineral Research (ASBMR) 2020 Annual Meeting, which this year takes place as a virtual event from the 11-15 September. NaQuinate, a n...

2020-09-10 17:34 3077

Bioserver.net - computation on living neurons is now available online

VEVEY, Switzerland, Sept. 10, 2020 /PRNewswire/ -- AlpVision SA, a global leader in advanced signal processing applications, just announced at the 2020-Intelligent Health Summit that the online access to the real-time electrical activity of living neurons is now available onBioServer.net

2020-09-10 14:00 2881

SonoScape Launches Latest High-end Ultrasound Systems - the Elite Series

SHENZHEN, China, Sept. 10, 2020 /PRNewswire/ -- SonoScape Medical Corporation introduced today its new generation high-end ultrasound systems: the ELITE series, integrating artificial intelligent solutions, advanced features, and remarkably improved system processing capability.

2020-09-10 10:06 3326

The Global Clinical CRO Fountain Medical Development and its Affiliates Rebrand as ClinChoice Inc

BEIJING and SHANGHAI, Sept. 9, 2020 /PRNewswire/ -- Fountain Medical Development (FMD K&L), together with its affiliates, is rebranding as ClinChoice Inc ("ClinChoice" or "Company"). ClinChoice is a global clinical stage Contract Research Organization ("CRO"), with over 1800 clinical research ...

2020-09-10 09:00 7811

The Biofactory Unveils New "Plug and Play" System Capable of Instantly Isolating Healthcare Facilities

SINGAPORE, Sept. 10, 2020 /PRNewswire/ -- The Biofactory, a Singapore-based biomedical technology manufacturer, unveiled a new portable "plug and play" system to isolate positively pressured healthcare facilities (Operating Theatres, Procedure Rooms and Intensive Care Units) and normal pressur...

2020-09-10 09:00 3901

DiscGenics Appoints Former Medtronic Spine and Biologics Finance Executive as First Chief Financial Officer

SALT LAKE CITY, Sept. 10, 2020 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced it has appointed former Medtronic ...

2020-09-10 08:30 2408

Taiwan's Chung Shan Medical University Hospital Joins TriNetX to Streamline Research and Accelerate Data Analysis

CAMBRIDGE, Massachusetts, Sept. 10, 2020 /PRNewswire/ -- Chung Shan Medical University Hospital (CSMUH), one of the three key medical centers located in mid-Taiwan, has joined the TriNetX network to improve medical information processing and to better harness data held within its electronic medic...

2020-09-10 08:00 2812

JYSK Taps Kӧrber for Supply Chain Megaproject in Hungary

Kӧrber's Depth and Vision Turns Supply Chain Complexity into a Strategic Differentiator for JYSK HAMBURG, Germany, Sept. 10, 2020 /PRNewswire/ -- Kӧrber, the global supply chain technology leader from software to materials handling automation, announces its selection by international Scandinavia...

2020-09-10 04:37 2388

Cyient Enters into a Manufacturing Collaboration with Agappe to Bring World-Class Diagnostic Capabilities to Rural India

HYDERABAD, India, Sept. 10, 2020 /PRNewswire/ -- Cyient, a global engineering and digital technology solutions company, today announced that it has entered into a manufacturing partnership with Agappe to bring to market Count X. The Mispa Count X is an indigenously designed and developed three-pa...

2020-09-10 02:54 2394

Direct Biologics Initiates Patient Enrollment in the Phase II EXIT COVID-19 Clinical Trial

Phase II Clinical Trial Initiated for ExoFlo Extracellular Vesicles in the Treatment of COVID-19 AUSTIN, Texas, Sept. 10, 2020 /PRNewswire/ -- Direct Biologics, LLC announced the launch today of EXIT COVID-19, their Phase II, multi-center clinical trial examining the use of ExoFlo™ extracellular...

2020-09-10 01:10 2255

Happiness Biotech Launched "Happy Buy", Dedicated to Boost its E-Commerce Business

NANPING, China, Sept. 9, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company has set up a wholly owned subsidiary "Happy Buy (Fujian) Internet Technology Co....

2020-09-09 22:00 10523

Clarity Pharmaceuticals Announces the US FDA Grants Rare Paediatric Disease Designation to 64Cu-SARTATE™, a diagnostic for the clinical management of neuroblastoma

SYDNEY, Sept. 9, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Rare Paediatric Disease Designation (RPDD) to64Cu-SARTATE™, ...

2020-09-09 21:13 1660
1 ... 624625626627628629630 ... 805